经皮腋动脉入路用于外周及复杂血管内介入:临床结局与成本效益
研究纳入2018年6月至2020年10月连续26例需上肢入路行复杂主动脉、心脏及外周血管内介入的患者,均采用超声引导经皮腋动脉入路并超说明书使用Perclose ProGlide预缝合技术,鞘管6–14F,技术成功率100%,无需要额外开放或血管内处理的重大围术期入路并发症,1例术后心肌梗死死亡。
要点
- 26例需上肢入路患者均行超声引导经皮腋动脉穿刺,超说明书使用Perclose ProGlide预缝合闭合。
- 鞘管尺寸6–14F,53%的病例使用12F或更大鞘管。
- 技术成功率100%,无需要额外干预的重大围术期入路并发症。
核心结论
- 数据再次显示经皮腋动脉入路具有安全性和有效性,并将其应用扩展至包括外周或冠状动脉血管介入以及复杂EVAR在内的广泛血管内介入。
研究设计与样本
- 2018年6月至2020年10月连续纳入26例需要上肢入路行血管内介入的患者。
- 所有26例均采用超声引导经皮腋动脉入路,超说明书使用Perclose ProGlide闭合装置行预缝合技术。
- 入路鞘管尺寸范围为6至14F。
- 终点为技术成功和入路相关并发症,包括孤立性神经病变、血肿、远端栓塞、入路部位血栓形成及需要二次干预的术后出血。
- 技术成功定义为术中成功闭合动脉,无狭窄、闭塞或持续出血证据且不需要额外干预。
主要发现
- 26例中15例行复杂血管内主动脉瘤修复(EVAR),使用分支、开窗、烟囱或平行内移植物;6例行外周血管介入;5例行心脏介入。
- 53%的病例使用12F或更大鞘管。
- 技术成功率为100%,无需要额外开放或血管内处理的重大围术期入路并发症。
- 本系列中1例有明显冠状动脉疾病的患者术后因心肌梗死死亡。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aim of this study was to determine the safety, efficacy, and applicability of percutaneous axillary artery (pAxA) access in patients requiring upper extremity large sheath access during complex aortic, cardiac, and peripheral endovascular procedures. We also take this opportunity to address the potential cost-benefits offered by pAxA access compared to open upper extremity access. METHODS: A total of 26 consecutive patients, between June 2018 and October 2020, underwent endovascular intervention, requiring upper extremity access (UEA). Ultrasound-guided, percutaneous access of the axillary artery was used in all 26 patients with off-label use of pre-close technique with Perclose ProGlide closure devices. Access sites accommodated sheath sizes that ranged from 6 to 14 French (F). End points were technical success and access site-related complications including isolated neuropathies, hematoma, distal embolization, access-site thrombosis, and post-operative bleeding requiring secondary interventions. Technical success was defined as successful arterial closure intraoperatively with no evidence of stenosis, occlusion, or persistent bleeding, requiring additional intervention. RESULTS: Of the 26 patients requiring pAxA access, 15 underwent complex endovascular aortic aneurysm repairs (EVAR) with branched, fenestrated, snorkel, or parallel endografts, 6 underwent peripheral vascular interventions, and 5 underwent cardiac interventions. Fifty-three percent accommodated sheath sizes of 12F or higher. Technical success was achieved in 100% of cases with no major perioperative access complications requiring additional open or endovascular procedures. In our series, we had one post-operative mortality secondary to myocardial infarction in a patient with significant coronary artery disease. CONCLUSIONS: Our data again demonstrated the proposed safety and efficacy attributable to pAxA access, while extending its application to wide spectrum of endovascular interventions which included peripheral or coronary vascular in addition to complex EVAR.
引用
- Yufa A, Mikael A, Gautier G, et al. Percutaneous Axillary Artery Access for Peripheral and Complex Endovascular Interventions: Clinical Outcomes and Cost Benefits. Ann Vasc Surg. 2021. PMID: 34954376. doi:10.1016/j.avsg.2021.11.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。